General | Carbohydrate O/F | Substrate utilisation | Enzymes | Metabolites | Antibiotics

Overview


  • Prevotella marshii is a Gram-negative, non-spore-forming, strictly anaerobic, non-motile, rod-shaped bacterium. It has been detected in at least 3 gut microbiome compilation studies or metastudies. The DNA G+C content is 47.5%. Prevotella marshii is probably a rare gut coloniser. (Hahnke2016; Downes2005)



  • This organism has been recovered from an oral cavity. The risk classification (www.baua.de) for this organism is 2, i.e., risk of individual infection, but low risk of spread. It is an opportunistic pathogen. A possible gut commensal.

  • GENERAL CHARACTERISTICS (Hahnke2016); (Downes2005);
    Character Response
  • Substrates hydrolysed or digested:
  • gelatin;
  • 💧
  • Bile tolerance:
  • Doesn't tolerate 20% bile
  • 🌡
  • Temperature tolerance:
  • grows at 37℃;
  • H+
  • Acid from carbohydrates usually produced:
  • glucose; maltose;
  • ±
  • Strain-dependent acid from carbs:
  • fructose; mannose;
  • Substrates assimilated or utilised:
  • fructose; glucose; maltose;
  • Active enzymes:
  • Ala arylamidase; alkaline phosphatase; α-glucosidase; Leu-Gly arylamidase; pyroGlu arylamidase;
  • ±
  • Strain-dependent active enzymes:
  • Glu-Glu arylamidase;

  • SPECIAL FEATURES (Hahnke2016); (Downes2005);
    Character Response
  • Metabolites produced:
  • acetate; propionate; succinate;
  • Metabolites not produced:
  • indole;
  • Nitrate:
  • not reduced
  • Pigments:
  • not produced

  • Details


    GENERAL
    Lineage Physiology General Growth Tolerances Hydrol./digest./degr.
    Phylum:  Bacteroidetes Class:  Bacteroidia Order:  Bacteroidales Family:  Prevotellaceae Genus:  Prevotella Gram stain:  neg O2 Relation.:  strictly anaerobic Spore:  No spore Motility:  Sessile Morphology:  Rod Pigment:  neg
    Health:  Unknown
    Source:  an oral cavity
    DNA G+C(%):  47.5
    Mid T(℃):  37(+)
    Bile reaction(%):  20(neg)
    Aesculin:  neg Urea:  neg Gelatin:  + Arginine:  neg

    CARBOHYDRATE ACID FORMATION
    Monosaccharide O/F Oligosaccharide O/F Polysaccharide O/F Polyol O/F Other O/F
    Arabinose:  neg Fructose:  d Glucose:  + Mannose:  d Rhamnose:  neg Ribose:  neg Cellubiose:  neg Lactose:  neg Maltose:  + Melezitose:  neg Melibiose:  neg Sucrose:  neg Trehalose:  neg Mannitol:  neg Sorbitol:  neg Salicin:  neg

    SUBSTRATE ASSIMILATION & UTILISATION
    Monosaccharide util/assim Oligosaccharide util/assim Other carboh. util/assim Amino acid util/assim Organic acid util/assim
    Fructose:  + Glucose:  + Maltose:  +

    ENZYME ACTIVITY
    Enzymes: General Enzymes: Carbohydrate Enzymes: Protein Enzymes: Arylamidases Enzymes: Esters/fats
    Catalase:  neg Urease:  neg G6PDH6PGDH:  neg α-Glucosidase:  + AlanineAA:  + GluGluAA:  d(w) LeuGlyAA:  + PyrogluAA:  + AlkalineP:  +

    METABOLITES - PRODUCTION & USE
    Fuel Usable Metabolites Metabolites Released Special Products Compounds Produced

    Acetate:  + Propionate:  + Succinate:  + Indole:  neg Pigment:  neg

    References


    SPECIFIC REFERENCES FOR PREVOTELLA MARSHII
  • Hahnke2016 - Description of Proteiniphilum saccharofermentans sp. nov., Petrimonas mucosa sp. nov. and Fermentimonas caenicola gen. nov., sp. nov., isolated from mesophilic laboratory-scale biogas reactors, and emended description of the genus Proteiniphilum.
  • Downes2005 - Prevotella marshii sp. nov. and Prevotella baroniae sp. nov., isolated from the human oral cavity.
  • Kishikawa2020 - Metagenome-wide association study of gut microbiome revealed novel aetiology of rheumatoid arthritis in the Japanese population
  • ...............................
  • GUT MICROBIOME COMPILATIONS AND METASTUDIES FOR PREVOTELLA MARSHII
  • Byrd2020 - Stability and dynamics of the human gut microbiome and its association with systemic immune traits.
  • De2020 - Metagenomic analysis of gut microbiome and resistome of diarrheal fecal samples from Kolkata, India, reveals the core and variable microbiota including signatures of microbial dark matter.
  • Zeller2014 - Potential of fecal microbiota for early-stage detection of colorectal cancer
  • ...............................